| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2022-02-09 | FMR LLC | NEKTAR THERAPEUTICS | 6,759,203 | 3.7% | EDGAR |
| SC 13G/A | 2022-02-04 | WELLINGTON MANAGEMENT GROUP LLP | NEKTAR THERAPEUTICS | 11,383,721 | 6.2% | EDGAR |
| SC 13G/A | 2022-01-27 | BlackRock Inc. | NEKTAR THERAPEUTICS | 26,671,803 | 14.5% | EDGAR |
| SC 13G/A | 2022-01-26 | BlackRock Inc. | NEKTAR THERAPEUTICS | 26,671,803 | 14.5% | EDGAR |
| SC 13G/A | 2022-01-10 | VANGUARD GROUP INC | NEKTAR THERAPEUTICS | 18,511,911 | 10.0% | EDGAR |
| SC 13G/A | 2021-12-10 | FMR LLC | NEKTAR THERAPEUTICS | 9,465,808 | 5.1% | EDGAR |
| SC 13G/A | 2021-02-12 | Invesco Ltd. | NEKTAR THERAPEUTICS | 35,456,949 | 19.8% | EDGAR |
| SC 13G/A | 2021-02-12 | PRIMECAP MANAGEMENT CO/CA/ | NEKTAR THERAPEUTICS | 18,440,399 | 10.3% | EDGAR |
| SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | NEKTAR THERAPEUTICS | 16,272,585 | 9.1% | EDGAR |
| SC 13G/A | 2021-02-08 | FMR LLC | NEKTAR THERAPEUTICS | 18,949,684 | 10.6% | EDGAR |
| SC 13G/A | 2021-02-04 | WELLINGTON MANAGEMENT GROUP LLP | NEKTAR THERAPEUTICS | 13,392,612 | 7.5% | EDGAR |
| SC 13G/A | 2021-01-27 | BlackRock Inc. | NEKTAR THERAPEUTICS | 18,378,080 | 10.2% | EDGAR |
| SC 13G/A | 2020-03-10 | FMR LLC | NEKTAR THERAPEUTICS | 18,698,403 | 10.5% | EDGAR |
| SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | NEKTAR THERAPEUTICS | 16,157,611 | 9.2% | EDGAR |
| SC 13G/A | 2020-02-12 | PRIMECAP MANAGEMENT CO/CA/ | NEKTAR THERAPEUTICS | 20,080,348 | 11.4% | EDGAR |
| SC 13G/A | 2020-02-07 | FMR LLC | NEKTAR THERAPEUTICS | 14,938,026 | 8.5% | EDGAR |
| SC 13G/A | 2020-02-07 | Invesco Ltd. | NEKTAR THERAPEUTICS | 31,629,134 | 18.0% | EDGAR |
| SC 13G/A | 2020-02-04 | BlackRock Inc. | NEKTAR THERAPEUTICS | 18,417,535 | 10.5% | EDGAR |
| SC 13G/A | 2020-01-27 | WELLINGTON MANAGEMENT GROUP LLP | NEKTAR THERAPEUTICS | 16,198,179 | 9.2% | EDGAR |
| SC 13G/A | 2019-11-08 | BlackRock Inc. | NEKTAR THERAPEUTICS | 18,726,518 | 10.7% | EDGAR |